Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDX-1100 with Methotrexate in Active Rheumatoid Arthritis
NCT01017367Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2008
- Primary completion
- Jan 2009
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of eldelumab in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Started Feb 2008; status: completed.
02
Drugs
eldelumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01017367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01017367.